# Unmasking an Intracardiac Shunt in a Case of Persistent Unexplained Hypoxia: A Case Report

**Authors:** Sanjay Sivalokanathan, Usman Saeedullah, Auston Locke, Maria Giovanna Trivieri

PMC · DOI: 10.3390/reports8010016 · 2025-01-26

## TL;DR

A 69-year-old woman with severe pulmonary hypertension and hypoxia was found to have an undiagnosed intracardiac shunt, which contributed to her condition and was addressed with combined therapies.

## Contribution

Highlights a rare case where an undiagnosed atrial septal defect worsened hypoxia in a patient with pulmonary hypertension.

## Key findings

- Right heart catheterization confirmed precapillary pulmonary hypertension with elevated pressures.
- A bubble study identified an intracardiac shunt as a contributing factor to persistent hypoxemia.
- Combination therapy with prostacyclin and vasopressors led to clinical stabilization.

## Abstract

Background and Clinical Significance: Pulmonary hypertension (PH) is characterized by an increase in mean pulmonary arterial pressure and pulmonary vascular resistance. It is frequently encountered in patients with significant intracardiac shunts, often necessitating the implementation of a closure device or surgical correction. Nevertheless, the occurrence of a concomitant atrial septal defect (ASD) with a right-to-left shunt inducing left ventricular dysfunction is a rare phenomenon. Case Presentation: A 69-year-old female patient with a history of heart failure (with preserved ejection fraction) and end-stage renal disease on hemodialysis presented to an outside facility, with syncope and hypoxia. She was recently diagnosed with severe pulmonary hypertension (measuring 86 mmHg). Right heart catheterization (RHC) revealed precapillary pulmonary hypertension (88/37/54 mmHg), prompting the initiation of intravenous epoprostenol. Nevertheless, the patient was persistently hypoxic, raising the possibility of a concomitant diagnosis. Upon review of the prior echocardiogram, which included a bubble study, an intracardiac shunt was identified. It was hypothesized that a combination of right ventricular failure and the right-to-left shunt resulting from the ASD contributed to the persistent hypoxemia. In light of this, prostacyclin therapy was continued alongside adjunctive vasopressors, resulting in clinical stabilization. The patient was eventually discharged with a treatment regimen that included subcutaneous Treprostinil. Conclusions: It is important to recognize that the consequences of PH are extensive, and that a rare yet significant etiology for persistent hypoxemia may be attributed to right-to-left shunting.

## Linked entities

- **Chemicals:** epoprostenol (PubChem CID 5282411), Treprostinil (PubChem CID 54786)
- **Diseases:** pulmonary hypertension (MONDO:0005149), heart failure (MONDO:0005252), end-stage renal disease (MONDO:0004375)

## Full-text entities

- **Diseases:** PH (MESH:D006976), left ventricular dysfunction (MESH:D018487), hypoxic (MESH:D002534), ASD (MESH:D006344), shunts (MESH:C562451), syncope (MESH:D013575), Hypoxia (MESH:D000860), heart failure (MESH:D006333), end-stage renal disease (MESH:D007676), right ventricular failure (MESH:D051437)
- **Chemicals:** Treprostinil (MESH:C427248), epoprostenol (MESH:D011464)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12199966/full.md

---
Source: https://tomesphere.com/paper/PMC12199966